Free Trial
NASDAQ:XCUR

Exicure (XCUR) Stock Price, News & Analysis

Exicure logo
$4.54 -0.36 (-7.35%)
Closing price 10/17/2025 04:00 PM Eastern
Extended Trading
$4.61 +0.07 (+1.43%)
As of 10/17/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Exicure Stock (NASDAQ:XCUR)

Advanced

Key Stats

Today's Range
$4.48
$4.98
50-Day Range
$3.51
$7.58
52-Week Range
$2.33
$36.00
Volume
31,503 shs
Average Volume
40,946 shs
Market Capitalization
$28.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

Exicure Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
24th Percentile Overall Score

XCUR MarketRank™: 

Exicure scored higher than 24% of companies evaluated by MarketBeat, and ranked 845th out of 950 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Exicure is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Exicure is -1.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Exicure has a P/B Ratio of 4.05. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Exicure's valuation and earnings.
  • Percentage of Shares Shorted

    1.95% of the float of Exicure has been sold short.
  • Short Interest Ratio / Days to Cover

    Exicure has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Exicure has recently increased by 5.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Exicure does not currently pay a dividend.

  • Dividend Growth

    Exicure does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.95% of the float of Exicure has been sold short.
  • Short Interest Ratio / Days to Cover

    Exicure has a short interest ratio ("days to cover") of 0.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Exicure has recently increased by 5.90%, indicating that investor sentiment is decreasing significantly.
  • MarketBeat Follows

    2 people have added Exicure to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Exicure insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    52.80% of the stock of Exicure is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    42.82% of the stock of Exicure is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Exicure's insider trading history.
Receive XCUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exicure and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

XCUR Stock News Headlines

This dark force is about to change everything
Something unusual is unfolding inside the Republican Party — from Marjorie Taylor Greene breaking ranks to Ted Cruz calling the White House a “mafia,” and even Trump’s approval rating slipping. But veteran analyst Porter Stansberry says this isn’t really about politics at all. It’s part of a much larger shift he calls The Final Displacement — a historic economic and social realignment already impacting millions of Americans. His new documentary explains what’s driving it and how to prepare before it accelerates further.tc pixel
See More Headlines

XCUR Stock Analysis - Frequently Asked Questions

Exicure's stock was trading at $13.67 at the beginning of the year. Since then, XCUR stock has decreased by 66.8% and is now trading at $4.54.

Exicure, Inc. (NASDAQ:XCUR) announced its earnings results on Friday, August, 8th. The company reported ($0.41) earnings per share for the quarter.

Shares of Exicure reverse split on the morning of Tuesday, August 27th 2024.The 1-5 reverse split was announced on Monday, August 26th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of XCUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Exicure investors own include Sorrento Therapeutics (SRNE), Allena Pharmaceuticals (ALNA), Tesla (TSLA), Meta Platforms (META), NIO (NIO), Viking Therapeutics (VKTX) and Energy Transfer (ET).

Company Calendar

Last Earnings
8/08/2025
Today
10/18/2025
Next Earnings (Estimated)
11/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:XCUR
CIK
1698530
Fax
N/A
Employees
50
Year Founded
2011

Profitability

EPS (Trailing Twelve Months)
($3.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.70 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-192.16%
Return on Assets
-84.30%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.89
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$500 thousand
Price / Sales
57.39
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.12 per share
Price / Book
4.05

Miscellaneous

Outstanding Shares
6,320,000
Free Float
2,982,000
Market Cap
$28.69 million
Optionable
Not Optionable
Beta
3.76

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:XCUR) was last updated on 10/18/2025 by MarketBeat.com Staff
From Our Partners